| Field test of quantum key distribution in the Tokyo QKD Network M Sasaki, M Fujiwara, H Ishizuka, W Klaus, K Wakui, M Takeoka, S Miki, ... Optics express 19 (11), 10387-10409, 2011 | 1243 | 2011 |
| Mullerian inhibiting substance in humans: normal levels from infancy to adulthood MM Lee, PK Donahoe, T Hasegawa, B Silverman, GB Crist, S Best, ... The Journal of Clinical Endocrinology & Metabolism 81 (2), 571-576, 1996 | 581 | 1996 |
| Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome Y Aoki, T Niihori, T Banjo, N Okamoto, S Mizuno, K Kurosawa, T Ogata, ... The American Journal of Human Genetics 93 (1), 173-180, 2013 | 355 | 2013 |
| SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7 S Narumi, N Amano, T Ishii, N Katsumata, K Muroya, M Adachi, ... Nature genetics 48 (7), 792-797, 2016 | 334 | 2016 |
| Developmental roles of the steroidogenic acute regulatory protein (StAR) as revealed by StAR knockout mice T Hasegawa, L Zhao, KM Caron, G Majdic, T Suzuki, S Shizawa, ... Molecular Endocrinology 14 (9), 1462-1471, 2000 | 298 | 2000 |
| Clinical Assessment and Mutation Analysis of Kallmann Syndrome 1 (KAL1) and Fibroblast Growth Factor Receptor 1 (FGFR1, or KAL2) in Five Families and 18 … N Sato, N Katsumata, M Kagami, T Hasegawa, N Hori, S Kawakita, ... The Journal of Clinical Endocrinology & Metabolism 89 (3), 1079-1088, 2004 | 277 | 2004 |
| Measurements of serum Müllerian inhibiting substance in the evaluation of children with nonpalpable gonads MM Lee, PK Donahoe, BL Silverman, T Hasegawa, Y Hasegawa, ... New England Journal of Medicine 336 (21), 1480-1486, 1997 | 258 | 1997 |
| Reduced phototoxicity of a fluoroquinolone antibacterial agent with a methoxy group at the 8 position in mice irradiated with long-wavelength UV light K Marutani, M Matsumoto, Y Otabe, M Nagamuta, K Tanaka, A Miyoshi, ... Antimicrobial agents and chemotherapy 37 (10), 2217-2223, 1993 | 211 | 1993 |
| Phenotypic spectrum of CHARGE syndrome with CHD7 mutations M Aramaki, T Udaka, R Kosaki, Y Makita, N Okamoto, H Yoshihashi, H Oki, ... The Journal of pediatrics 148 (3), 410-414, 2006 | 196 | 2006 |
| GATA3 abnormalities and the phenotypic spectrum of HDR syndrome K Muroya, T Hasegawa, Y Ito, T Nagai, H Isotani, Y Iwata, K Yamamoto, ... Journal of medical genetics 38 (6), 374-380, 2001 | 178 | 2001 |
| Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients M Fukami, R Horikawa, T Nagai, T Tanaka, Y Naiki, N Sato, T Okuyama, ... The Journal of Clinical Endocrinology & Metabolism 90 (1), 414-426, 2005 | 169 | 2005 |
| Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone K Homma, T Hasegawa, T Nagai, M Adachi, R Horikawa, I Fujiwara, ... The Journal of Clinical Endocrinology & Metabolism 91 (7), 2643-2649, 2006 | 166 | 2006 |
| CXorf6 is a causative gene for hypospadias M Fukami, Y Wada, K Miyabayashi, I Nishino, T Hasegawa, ... Nature genetics 38 (12), 1369-1371, 2006 | 163 | 2006 |
| Physical mapping of the split hand/split foot locus on chromosome 7 and implication in syndromic ectrodactyly S W. Scherer, P Poorka], H Massa, S Soder, T Allen, M Nunes, D Geshurl, ... Human molecular genetics 3 (8), 1345-1354, 1994 | 141 | 1994 |
| PTPN11 (Protein-Tyrosine Phosphatase, Nonreceptor-Type 11) Mutations in Seven Japanese Patients with Noonan Syndrome K Kosaki, T Suzuki, K Muroya, T Hasegawa, S Sato, N Matsuo, R Kosaki, ... The Journal of Clinical Endocrinology & Metabolism 87 (8), 3529-3533, 2002 | 137 | 2002 |
| Heterozygous Mutations in Natriuretic Peptide Receptor-B (NPR2) Gene as a Cause of Short Stature in Patients Initially Classified as Idiopathic Short Stature GA Vasques, N Amano, AJ Docko, MFA Funari, EPS Quedas, MY Nishi, ... The Journal of Clinical Endocrinology & Metabolism 98 (10), E1636-E1644, 2013 | 135 | 2013 |
| Cytochrome P450 oxidoreductase deficiency: identification and characterization of biallelic mutations and genotype-phenotype correlations in 35 Japanese patients M Fukami, G Nishimura, K Homma, T Nagai, K Hanaki, A Uematsu, T Ishii, ... The Journal of Clinical Endocrinology & Metabolism 94 (5), 1723-1731, 2009 | 133 | 2009 |
| Protein-tyrosine phosphatase, nonreceptor type 11 mutation analysis and clinical assessment in 45 patients with Noonan syndrome R Yoshida, T Hasegawa, Y Hasegawa, T Nagai, E Kinoshita, Y Tanaka, ... The Journal of Clinical Endocrinology & Metabolism 89 (7), 3359-3364, 2004 | 130 | 2004 |
| An HDR (hypoparathyroidism, deafness, renal dysplasia) syndrome locus maps distal to the DiGeorge syndrome region on 10p13/14 P Lichtner, R König, T Hasegawa, H Van Esch, T Meitinger, ... Journal of medical genetics 37 (1), 33-37, 2000 | 129 | 2000 |
| Transcription factor mutations and congenital hypothyroidism: systematic genetic screening of a population-based cohort of Japanese patients S Narumi, K Muroya, Y Asakura, M Adachi, T Hasegawa The Journal of Clinical Endocrinology & Metabolism 95 (4), 1981-1985, 2010 | 127 | 2010 |
